Peter G. Edwards - 08 Sep 2022 Form 4 Insider Report for AZIYO BIOLOGICS, INC. (ELUT)

Role
GENERAL COUNSEL
Signature
/s/ Jeffrey Hamet, Attorney-in-Fact for Peter G. Edwards
Issuer symbol
ELUT
Transactions as of
08 Sep 2022
Transactions value $
-$8,227
Form type
4
Filing time
12 Sep 2022, 17:09:20 UTC
Previous filing
10 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELUT Class A Common Stock Options Exercise +4.63K 4.63K 08 Sep 2022 Direct F1
transaction ELUT Class A Common Stock Tax liability -$8.23K -1.13K -24.37% $7.30* 3.5K 08 Sep 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELUT Restricted Stock Units Options Exercise $0 -4.63K -100% $0.00* 0 08 Sep 2022 Class A Common Stock 4.63K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units.
F2 Shares withheld by the Issuer to satisfy tax withholding requirements on vesting of restricted stock units.
F3 The restricted stock units granted on March 8, 2022 vested in full on September 8, 2022.